A fourth dose of bivalent or monovalent BA.1-adapted BNT162b2 vaccines was safe and elicited robust neutralizing responses in adults aged 18 to 55 years.
When the X user shared the post in June 2013, there was a fresh outbreak of MERS-coronavirus in Saudi Arabia.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results